Occurrence of Metallo-Beta-Lactamase-Producing Enterobacteriaceae from a Local Poultry Farm in Abakaliki, Nigeria

Ejikeugwu Chika, Iroha Ifeanyichukwu, Duru Carissa, Ayogu Thomas, Orji Okoro, Eze Joshua, Adikwu Michael, Esimone Charles


The production of beta-lactamases especially the expanded/extended beta-lactamases such as the metallo beta-lactamase (MBL) enzymes by Gram negative bacteria (GNB) are amongst the top arsenal of pathogenic bacteria used to make the therapeutic effect of some available drugs less efficacious. This study evaluated the phenotypic production of MBLs from 50 cloacal swabs of poultry birds in a poultry farm in Abakaliki metropolis, Ebonyi State, Nigeria. The samples were bacteriologically analyzed using eosin methylene blue (EMB) agar and MacConkey agar; and MBL production was phenotypically detected using the Kirby-Bauer disk diffusion method (for antibiogram) and the inhibition based assay technique (for MBL production). Out of the 50 cloacal swab samples analyzed in this study, 39 isolates were Escherichia coli while 33 isolates were positive for Klebsiella species. All the E. coli and Klebsiella species showed high resistance to most of the tested antibiotics especially to imipenem, meropenem, ciprofloxacin, sulphamethoxazole trimethoprim, cefoxitin, ertapenem and gentamicin. Nine (9) isolates of E. coli (23.1 %) were phenotypically detected as MBL producers while 6 isolates of Klebsiella species (18.2 %) were confirmed as MBL producing strains. This present day study accentuates the growing resistance mechanism in the community; and thus calls for concerted effort to detect and prevent the dissemination of antibiotic resistant microbes in the community. Further molecular characterization is required to classify the genetic elements responsible for the dissemination of MBL-producing microbes in this environment.


Metallo Beta-Lactamases; Occurrence; Enterobacteriaceae; Community-Acquired; Infections; Nigeria

Full Text:



Aibinu I., Nwanneka T and Odugbemi T (2007). Occurrence of ESBLs and MBL in Clinical Isolates of Pseudomonas aeruginosa from Lagos, Nigeria. Journal of American Sciences, 3(4):81-85.

Akinduti P.A, Ejilude O, Motayo B.O and Adeyokinu A.F (2012). Emerging multidrug resistant AmpC beta-lactamase and carbapenemase enteric isolates in Abeokuta, Nigeria. Nature and Sceince, 10(7):70-74.

Bush K and Jacoby G.A (2010). Updated functional classification of β – Lactamases. Antimicrobial agents Chemotherapy, 54(3):969-976.

Chakraborty D., Basu S and Das S (2010). A study on infections caused by Metallo Beta Lactamase Producing Gram negative Bacteria in Intensive Care Unit Patients. American Journal of infectious Diseases, 6(2):34-39.

Cheesbrough M (2000). District Laboratory Practice in Tropical Countries. 2nd edition. Cambridge University Press, UK. Pp. 178-187.

Clinical Laboratory Standard Institute, CLSI, (2005). Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement. CLSI document M100-S15. CLSI, Wayne, PA. http://www.fsis.usda.gov

Ejikeugwu C, Esimone C, Iroha I, Ugwu C, Ezeador C, Duru C, Adikwu M (2016). Phenotypic detection of AmpC beta-lactamase among anal Pseudomonas aeruginosa isolates in a Nigerian abattoir. Archives of Clinical Microbiology, 7(2):1-5.

Ejikeugwu PC, Ugwu CM., Iroha IR., Eze P, Gugu TH and Esimone CO (2014). Phenotypic Detection of Metallo-β-Lactamase Enzyme in Enugu, Southeast Nigeria. American Journal of Biological, Chemical and Pharmaceutical Science, 2(2):1-6.

Eze E, Nwakaeze E, Oji A, Ejikeugwu C, Iroha I (2013). Microbiological investigation of Escherichia coli isolates from cloacal and feacal swabs of broiler chickens for extended spectrum beta lactamase (ESBL) enzymes. IOSR Journal of Pharmacy and Biological Sciences. 7(5):96-99.

Franco M.R.G., Caiaffa-Filho H.H., Burattini M.N and Rossi F (2010). Metallo – beta – lactamases among imipenem resistant Pseudomonas aeruginosa in a Brazillian University hospital. Clinics, 65(9):825-829.

Franklin C., Liolios L and Peleg A.Y (2006). Phenotypic Detection of Carbapenem – Susceptible Metallo – β – Lactamase – Producing Gram-Negative Bacilli in the Clinical Laboratory. Journal of Clinical Microbiology, 44(9):3139-3144.

Jacoby G.A and Munoz-Price L.S (2005). Mechanisms of Disease: The New β – Lactamases. N Engl J Med, 352:380-91.

Nwankwo C, Ayogu T, Iroha I, Ejikeugwu C, Nwakaeze E, Oji A and ILang D (2014). Cloacal

feacal carriage and occurrence of antibiotic resistant Escherichia coli in chicken grown with and without antibiotic supplemented feed. Journal of Veterinary Medicine and Animal Health, 6(3):91-94.

Pitout J.D.D., Chow B.L., Gregson D.B., Laupland K.B., Elsayed S and Church D.L (2007). Molecular epidemiology of Metallo – β – Lactamase - producing Pseudomonas aeruginosa in the Calgary Health Region: Emergence of VIM-2 producing isolates. Journal of Clinical Microbiology, 45(2):294-298.

Saderi H., Karimi Z., Owlia P., Bahar M.A., Rad S.M (2008). Phenotypic detection of metallo – beta – lactamase producing Pseudomonas aeruginosa strains isolated from burned patients. Iranian Journal of Pathology, 3(1):20-24.

Varaiya A., Kulkarni N., Kulkarni M., Bhalekar P and Dogra J (2008). Incidence of metallo beta – lactamase producing Pseudomonas aeruginosa in ICU patients. Indian J Med Res, 127:398-402.

Walsh T.R., Toleman M.A., Poirel L and Nordmann P (2005). Metallo – β – lactamases: the Quiet before the storm? Clinical Microbiology Review, 18(2):306-325.

DOI: http://dx.doi.org/10.21477/ijapsr.v1i2.10178


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Creative Commons License
International Journal of Applied Pharmaceutical Sciences and Research by Sierra Journals is licensed under a creativecommons.org/licenses/by/4.0/. https://creativecommons.org/licenses/by/4.0/
Based on a work at http://www.sierrajournals.com/direct/index.php/IJAPSR/issue/archive